Oncogenes and Angiogenesis: down-regulation of thrombospondin-1 in normal fibroblasts exposed to factors from cancer cells harboring mutant ras.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Research

• Publication date

  2005-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-1479PMID 16204059
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FTY720: Sphingosine 1‐Phosphate Receptor‐1 in the Control of Lymphocyte Egress and Endothelial Barrier Function

  2004cited by this paper
• Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis.

  2003influential reference
• Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors.

  2003cited by this paper
• Sphingosine-1-phosphate: an enigmatic signalling lipid

  2003cited by this paper
• Cell density regulates thrombospondin-1 production in malignant glioma cells

  2003cited by this paper
• Restoration of thrombospondin 1 expression in tumor cells harbouring mutant ras oncogene by treatment with low doses of doxycycline.

  2003cited by this paper
• Contrasting effects of VEGF gene disruption in embryonic stem cell‐derived versus oncogene‐induced tumors

  2003influential reference
• Thrombospondin‐1 as an endogenous inhibitor of angiogenesis and tumor growth

  2002cited by this paper
• Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1.

  2002influential reference
• Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium–derived factor

  2002cited by this paper
• Expression and role of thrombospondin-1 in colorectal cancer.

  2002cited by this paper
• VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.

  2002cited by this paper
• Angiogenesis Research: Guidelines for Translation to Clinical Application

  2001cited by this paper
• Thrombospondins as matricellular modulators of cell function.

  2001cited by this paper
• An oncogenic role of sphingosine kinase.

  2000cited by this paper
• Oncogenes and angiogenesis: signaling three-dimensional tumor growth.

  2000cited by this paper
• Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts.

  2000influential reference
• Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts

  1999cited by this paper
• The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun

  1999cited by this paper
• Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways.

  1997cited by this paper
• How tumors become angiogenic.

  1996cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Both v-Ha-Ras and v-Raf Stimulate Expression of the Vascular Endothelial Growth Factor in NIH 3T3 Cells (*)

  1995cited by this paper
• Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.

  1995cited by this paper
• SPARC and thrombospondin genes are repressed by the c‐jun oncogene in rat embryo fibroblasts.

  1994cited by this paper
• Overlapping Egr-1 and Sp1 sites function in the regulation of transcription of the mouse thrombospondin 1 gene.

  1994cited by this paper
• Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines

  1994cited by this paper
• Altered growth of human colon cancer cell lines disrupted at activated Ki-ras.

  1993cited by this paper

• Cell facilitation promotes growth and survival under drug pressure in breast cancer

  2023cites this paper
• Counter Regulation of Tumor Angiogenesis by Vascular Endothelial Growth Factor and Thrombospondin-1.

  2022cites this paper
• Sutural fibroblasts exhibit the function of vascular endothelial cells upon mechanical strain.

  2021cites this paper
• Facilitation drives estrogen receptor positive (ER+) breast cancer growth and survival under drug pressure Authors:

  2021cites this paper
• Ecological interactions in breast cancer: Cell facilitation promotes growth and survival under drug pressure

  2021cites this paper
• A statistical test for clonal exclusivity in tumour evolution

  2021cites this paper
• Contemporary nano-architectured drugs and leads for ανβ3 integrin-based chemotherapy: Rationale and retrospect

  2021cites this paper
• Statistical tests for intra-tumour clonal co-occurrence and exclusivity

  2021cites this paper
• Thrombospondin in Tumor Microenvironment.

  2020cites this paper
• Tumor Microenvironment: Extracellular Matrix Components – Part B

  2020cites this paper
• Oncogenic Regulation of Extracellular Vesicle Proteome and Heterogeneity

  2019cites this paper
• The Role of Calcineurin/NFAT Signaling in Fibroblast Homeostasis and Activation

  2019cites this paper
• The essence of the new blood vessels formation process in cancers based on the example of triple-negative breast cancer

  2019cites this paper
• Intra-tumor heterogeneity and clonal exclusivity in renal cell carcinoma

  2018cites this paper
• Extracellular vesicle communication pathways as regulatory targets of oncogenic transformation.

  2017cites this paper
• Barriers to horizontal cell transformation by extracellular vesicles containing oncogenic H-ras

  2016cites this paper
• The anticancer potential of thrombospondin-1 by inhibiting angiogenesis and stroma reaction during cervical carcinogenesis

  2016cites this paper
• The diagnostic performance parameters of Narrow Band Imaging: A preclinical and clinical study.

  2016cites this paper
• The Functional Evolution of Human microRNA Families

  2016cites this paper
• Stromal fibroblast activation and their potential association with uterine fibroids (Review)

  2014cites this paper
• 3′LIFE: a functional assay to detect miRNA targets in high-throughput

  2014cites this paper
• Abstract 190: The anti-cancer potential of thrombospondin-1 by inhibiting angiogenesis and stroma reaction during cervical carcinogenesis

  2014cites this paper
• Non‐Cell Autonomous or Secretory Tumor Suppression

  2014cites this paper
• ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities.

  2014cites this paper
• Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations

  2014cites this paper
• Decorin Induces Mitophagy in Breast Carcinoma Cells via Peroxisome Proliferator-activated Receptor γ Coactivator-1α (PGC-1α) and Mitostatin*

  2014cites this paper
• Targeting Tumour Vasculature with Oncolytic Viruses

  2014cites this paper
• Decorin induces rapid secretion of thrombospondin‐1 in basal breast carcinoma cells via inhibition of Ras homolog gene family, member A/Rho‐associated coiled‐coil containing protein kinase 1

  2013cites this paper
• We review the function of these different proteins , the incidence of mutations in their genes in carcinogenesis and as potential prognostic factors in sporadic and hereditary ovarian cancer

  2013cites this paper
• COX-2 overexpression increases malignant potential of human glioma cells through Id1

  2013cites this paper
• Thrombospondin-1 receptor mediates autophagy of RAS-expressing cancer cells and triggers tumour growth inhibition.

  2013cites this paper
• Thrombospondin-1 Is a Putative Target Gene of Runx2 and Runx3

  2013cites this paper
• First steps in experimental cancer evolution

  2013cites this paper
• Genetic pathways linking hemostasis and cancer.

  2012cites this paper
• The role of the tumor microenvironment in regulating angiogenesis.

  2012cites this paper
• H‐Ras increases release of sphingosine resulting in down‐regulation of TSP‐1 in non‐transformed cells

  2012influential citation
• Angiogenesis and invasion in cancer.

  2012cites this paper
• Development of a Cancer Vaccine Targeting Tumor Blood Vessels

  2012cites this paper
• The thrombospondins.

  2011cites this paper
• H-ras up-regulates expression of BNIP3.

  2011cites this paper
• H-ras Upregulates Expression of BNIP 3

  2011cites this paper
• Pretreatment hepatocyte growth factor and thrombospondin-1 levels predict response to high-dose chemotherapy for multiple myeloma.

  2010cites this paper
• RAS Oncogenes and Tumor-Vascular Interface

  2010cites this paper
• Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) — a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia

  2010cites this paper
• Microparticles in cancer.

  2010cites this paper
• Microparticles in Cancer

  2010cites this paper
• Levels of angiogenic factors in patients with multiple myeloma correlate with treatment response

  2010cites this paper
• Tenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro

  2010cites this paper
• Angiogenesis and Lymphangiogenesis in Colon Cancer Metastasis

  2010cites this paper
• Introduction to the Tumour Microenvironment Review Series

  2009cites this paper
• Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1

  2009cites this paper
• Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer

  2009cites this paper
• [Hypoxia in cancer malignity. Review].

  2009cites this paper
• Anti-Angiogenic Therapy with Thrombospondins

  2008cites this paper
• Contribution of Host-Derived Tissue Factor to Tumor Neovascularization

  2008cites this paper
• A novel role of thrombospondin-1 in cervical carcinogenesis: inhibit stroma reaction by inhibiting activated fibroblasts from invading cancer.

  2008cites this paper
• The helix-loop-helix protein Id1 requires cyclin D1 to promote the proliferation of mammary epithelial cell acini.

  2008cites this paper
• Metronomic chemotherapy : A new approach in cancer therapy

  2008cites this paper
• Regulation of tumor dormancy as a function of tumor‐mediated paracrine regulation of stromal Tsp‐1 and VEGF expression  

  2008cites this paper
• Regulation of Angiogenesis and Tumor Growth by Thrombospondin-1

  2008cites this paper
• Thrombospondins: from structure to therapeutics

  2008cites this paper
• Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments.

  2008cites this paper
• Chemioterapia metronomiczna jako nowa strategia leczenia chorób nowotworowych* Metronomic chemotherapy: A new approach in cancer therapy

  2008cites this paper
• Vascular determinants of cancer stem cell dormancy—do age and coagulation system play a role?  

  2008cites this paper
• [Metronomic chemotherapy: a new approach in cancer therapy].

  2008cites this paper
• Inhibitor of DNA Binding 1 Activates Vascular Endothelial Growth Factor through Enhancing the Stability and Activity of Hypoxia-Inducible Factor-1α

  2007cites this paper
• [Tumor angiogenesis].

  2007cites this paper
• Differences in the regulation of Thrombospondin-1 expression between epithelial cells and fibroblasts

  2007cites this paper
• Angiogenesis: molecular mechanisms of activation, promotion and maintenance.

  2007cites this paper
• Kaposi's Sarcoma-Associated Herpesvirus Promotes Angiogenesis by Inducing Angiopoietin-2 Expression via AP-1 and Ets1

  2007cites this paper
• Thrombospondin-based antiangiogenic therapy.

  2007cites this paper
• Tissue Factor in Cancer and Angiogenesis: The Molecular Link between Genetic Tumor Progression, Tumor Neovascularization, and Cancer Coagulopathy

  2006cites this paper
• Evolution of cooperation among tumor cells

  2006cites this paper
• Angiogenesis : health and disease

  2006cites this paper
• Angiogenesis: health and disease.

  2006cites this paper
• Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy.

  2006cites this paper